We are live on ! Find out more
D.E. Shaw & Co

D.E. Shaw & Co Portfolio holdings

AUM $166B
1-Year Est. Return 43.98%
 

D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.

This Fund
S&P 500
This Quarter Est. Return
-1.54%
1 Year Est. Return
+43.98%
3 Year Est. Return
+138.44%
5 Year Est. Return
+164.23%
10 Year Est. Return
+713.02%
AUM
$83.7B
AUM Growth
-$1.57B
Cap. Flow
-$3.66B
Cap. Flow %
-4.37%
Top 10 Hldgs %
8.74%
Holding
5,820
New
545
Increased
1,802
Reduced
1,597
Closed
679

Top Buys

Rank Stock Value
1
V icon
Visa
V
+$365M
2
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$307M
3
ADBE icon
Adobe
ADBE
+$250M
4
NVDA icon
NVIDIA
NVDA
+$242M
5
CRM icon
Salesforce
CRM
+$240M

Sector Composition

Rank Sector Weight
1 Technology 13.14%
2 Financials 9.37%
3 Healthcare 7.49%
4 Consumer Discretionary 6.79%
5 Communication Services 4.95%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TRIP icon
4101
PUT
TripAdvisor
TRIP
$1.72B
$331K ﹤0.01%
15,000
ATRI
4102
DELISTED
Atrion Corp
ATRI
$331K ﹤0.01%
586
VMD icon
4103
Viemed Healthcare
VMD
$469M
$330K ﹤0.01%
54,860
-161,806
-75% -$1.04M
HCI icon
4104
PUT
HCI Group
HCI
$2.26B
$329K ﹤0.01%
8,400
RNWWW
4105
ReNew Energy Global PLC Warrant
RNWWW
$64.8K
$329K ﹤0.01%
315,968
+3,705
+1% +$4.74K
MCS icon
4106
Marcus Corp
MCS
$761M
$328K ﹤0.01%
23,626
+8,722
+59% +$140K
QSI icon
4107
Quantum-Si Incorporated
QSI
$165M
$328K ﹤0.01%
119,373
-32,206
-21% -$103K
SAFE
4108
CALL
Safehold
SAFE
$1.21B
$324K ﹤0.01%
+7,190
New +$499K
VIVO
4109
DELISTED
Meridian Bioscience Inc
VIVO
$322K ﹤0.01%
+10,200
New +$330K
VET icon
4110
PUT
Vermilion Energy
VET
$1.62B
$321K ﹤0.01%
15,000
-235,000
-94% -$5.52M
HCI icon
4111
HCI Group
HCI
$2.26B
$319K ﹤0.01%
8,133
-13,873
-63% -$796K
ZIM icon
4112
ZIM Integrated Shipping Services
ZIM
$2.92B
$319K ﹤0.01%
+13,578
New +$561K
FMTX
4113
DELISTED
Forma Therapeutics Holdings, Inc. Common Stock
FMTX
$319K ﹤0.01%
16,010
-66,485
-81% -$877K
HFWA icon
4114
Heritage Financial
HFWA
$1.22B
$318K ﹤0.01%
11,997
-17,210
-59% -$454K
NRDY icon
4115
Nerdy
NRDY
$111M
$318K ﹤0.01%
150,804
+20,088
+15% +$53.8K
HWEL
4116
DELISTED
Healthwell Acquisition Corp. I Class A Common Stock
HWEL
$318K ﹤0.01%
32,800
CHCO icon
4117
City Holding Co
CHCO
$2.06B
$316K ﹤0.01%
3,560
-1,478
-29% -$126K
IRBT
4118
DELISTED
iRobot
IRBT
$315K ﹤0.01%
5,590
-189,666
-97% -$9.95M
MED icon
4119
Medifast
MED
$108M
$315K ﹤0.01%
2,903
+1,679
+137% +$241K
SRTS icon
4120
Sensus Healthcare
SRTS
$49.7M
$315K ﹤0.01%
25,150
+5,555
+28% +$66.4K
BKI
4121
DELISTED
Black Knight, Inc. Common Stock
BKI
$315K ﹤0.01%
4,862
-14,521
-75% -$956K
OPRT icon
4122
Oportun Financial
OPRT
$265M
$313K ﹤0.01%
71,506
-82,370
-54% -$585K
POSH
4123
PUT
DELISTED
Poshmark, Inc. Class A Common Stock
POSH
$313K ﹤0.01%
20,000
BLUE
4124
DELISTED
bluebird bio
BLUE
$311K ﹤0.01%
2,459
-31,289
-93% -$3.54M
FHLT
4125
DELISTED
Future Health ESG Corp. Common stock
FHLT
$311K ﹤0.01%
31,061

Similar funds

D.E. Shaw & Co's Q3 2022 Portfolio in Review

As of Q3 2022, D.E. Shaw & Co held 5,820 positions worth $83.7B, down 1.8% from $85.3B the previous quarter. Its ten largest holdings account for 8.7% of the portfolio.

D.E. Shaw & Co withdrew a net $3.66B in Q3 2022, closing 679 positions and reducing 1,597 holdings. Its most notable exit was iShares MSCI Emerging Markets ETF, an estimated $171M position sold in full.

By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 12% a quarter earlier, followed by Financials and Healthcare.

Against the trend, D.E. Shaw & Co opened a new position in Prologis worth $66.1M.

  • D.E. Shaw & Co's largest Q3 2022 buy was Prologis: 650,725 shares worth $66.1M.
  • D.E. Shaw & Co added most to Visa in Q3 2022, an estimated $365M increase.
  • D.E. Shaw & Co's biggest Q3 2022 reduction was PayPal, cutting an estimated $520M.
  • D.E. Shaw & Co fully exited iShares MSCI Emerging Markets ETF in Q3 2022, selling an estimated $171M.
  • D.E. Shaw & Co's ten largest holdings make up 8.7% of its $83.7B portfolio in Q3 2022.
  • D.E. Shaw & Co opened 545 new positions and closed 679 in Q3 2022.
  • D.E. Shaw & Co's portfolio value fell 1.8% quarter-over-quarter to $83.7B.

Based on D.E. Shaw & Co's 13F filing for Q3 2022, filed 14 Nov 2022.